Linaclotide is a 14-amino acid guanylate cyclase C (GC-C) agonist. Its mechanism of action involves binding to GC-C in the intestine, thereby increasing the concentration of intracellular cyclic guanosine monophosphate (cGMP) and promoting intestinal fluid secretion, thereby exerting its biological activity.